Quick Answer
Camp4 Therapeutics Corp reported Research And Development Expense of $38.20 million for the year ending 2025.
- Camp4 Therapeutics Corp showed a decrease of -1.6% in Research And Development Expense from 2024 to 2025.
- This data is from Camp4 Therapeutics Corp's annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2023: $9.82 million | Q1 2024: $9.74 million | Q2 2024: $9.39 million | Q3 2024: $9.70 million | Q1 2025: $10.15 million | Q2 2025: $10.34 million | Q3 2025: $9.36 million.
- Over the full 3 years of available data (2023 to 2025), Camp4 Therapeutics Corp's Research And Development Expense has declined by 5.9%.
- Historical annual values: Fiscal year 2025: $38.20 million | Fiscal year 2024: $38.82 million | Fiscal year 2023: $40.62 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: